Aspirin

Generic Name
Aspirin
Brand Names
Aggrenox, Alka-seltzer, Alka-seltzer Fruit Chews, Anacin, Arthriten Inflammatory Pain, Ascomp, Aspi-cor, Aspir-low, Bayer Aspirin, Bayer Womens, Bc Arthritis, Bc Original Formula, Bufferin, Duoplavin, Durlaza, Ecotrin, Ecpirin, Endodan Reformulated May 2009, Equagesic, Exaprin, Excedrin, Excedrin PM Triple Action, Fasprin, Fiorinal, Goody's Body Pain, Goody's Extra Strength, Goody's PM, Miniprin, Norgesic, Norgesic Forte, Orphengesic, Pamprin Max Formula, Robaxisal, ST. Joseph Aspirin, Stanback Headache Powder Reformulated Jan 2011, Trianal, Trianal C, Vanquish, Vazalore, Yosprala
Drug Type
Small Molecule
Chemical Formula
C9H8O4
CAS Number
50-78-2
Unique Ingredient Identifier
R16CO5Y76E
Background

Also known as Aspirin, acetylsalicylic acid (ASA) is a commonly used drug for the treatment of pain and fever due to various causes. Acetylsalicylic acid has both anti-inflammatory and antipyretic effects. This drug also inhibits platelet aggregation and is used in the prevention of blood clots stroke, and myocardial infarction (MI) .
...

Indication

Pain, fever, and inflammation
...

Associated Conditions
Acute Coronary Syndrome (ACS), Anxiety, Atherothrombotic cerebral infarction, Cardiovascular Disease (CVD), Cardiovascular Events, Cardiovascular Mortality, Colorectal Adenomas, Colorectal Cancer, Common Cold, Coronary artery reocclusion, Death, Dyspeptic signs and symptoms, Fever, Flu caused by Influenza, Headache, Heterozygous Familial Hypercholesterolemia (HeFH), Inflammation, Juvenile Idiopathic Arthritis (JIA), Major Adverse Cardiovascular and Cerebrovascular Events (MACCE), Menstrual Pain, Migraine, Morbidity, Mucocutaneous Lymph Node Syndrome, Muscle Contraction, Myalgia, Myocardial Infarction, Myocardial Infarction (MI), first occurrence, Neuropathic Pain, Pain, Pain caused by Common Cold, Pain caused by Rheumatism, Pericarditis, Polycythemia Vera (PV), Pre-Eclampsia, Rheumatism, Rheumatoid Arthritis, Rhino Sinusitis, Severe Pain, Spondyloarthropathies, Stroke, Systemic Lupus Erythematosus, Tension Headache, Thromboembolism, Thrombosis, Toothache, Transient Ischemic Attack, Vascular Death, Venous Thromboembolism, Acute Inflammation, Articular inflammation, Atherothrombotic events, Death caused by Myocardial Infarction, Fever or influenza-like illness, Moderate Pain, Recurrent Ischemic Stroke
Associated Therapies
Anti-platelet Therapy, Hemodialysis Treatment, Secondary Prevention

Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)

First Posted Date
2024-08-12
Last Posted Date
2024-11-13
Lead Sponsor
Capital Medical University
Target Recruit Count
1184
Registration Number
NCT06548971
Locations
🇨🇳

The Third The People's Hospital Of Bengbu, Bengbu, Anhui, China

🇨🇳

Xuanwu Hospital, Capital Medical University, Beijing, Beijing, China

🇨🇳

The First Affiliated Hospital of Chongqing Medical and Pharmaceutical College, Chongqing, Chongqing, China

and more 20 locations

Effect of Low Molecular Heparin on Pregnancy Outcome With Protein S Deficiency

Phase 2
Not yet recruiting
Conditions
Interventions
First Posted Date
2024-08-01
Last Posted Date
2024-08-01
Lead Sponsor
Peking University People's Hospital
Target Recruit Count
48
Registration Number
NCT06531525
Locations
🇨🇳

Peking University Insititute of Hematology, Peking University People's Hospital, Beijing, Beijing/Beijing, China

Cilostazol vs. Aspirin in Acute Non-cardioembolic Stroke With Cerebral mIcrobleeds

Phase 3
Recruiting
Conditions
Interventions
First Posted Date
2024-07-31
Last Posted Date
2024-07-31
Lead Sponsor
Zhejiang Provincial People's Hospital
Target Recruit Count
848
Registration Number
NCT06530537
Locations
🇨🇳

Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China

Short Versus Long Antiplatelet Therapy After TAVI

Phase 3
Not yet recruiting
Conditions
Interventions
First Posted Date
2024-07-24
Last Posted Date
2024-07-24
Lead Sponsor
University Hospital, Caen
Target Recruit Count
1400
Registration Number
NCT06518317

The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity

First Posted Date
2024-07-10
Last Posted Date
2024-07-10
Lead Sponsor
University of Calgary
Target Recruit Count
8805
Registration Number
NCT06494878
Locations
🇨🇦

Foothills Medical Centre, Calgary, Alberta, Canada

🇨🇦

Mount Sinai Hospital, Toronto, Ontario, Canada

🇨🇦

The Ottawa Hospital - General Campus, Ottawa, Ontario, Canada

Stroke Prevention In Ischemic Stroke With Covert Atrial Fibrillation

First Posted Date
2024-07-05
Last Posted Date
2024-07-05
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Target Recruit Count
1148
Registration Number
NCT06486792

TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment Termination

First Posted Date
2024-06-27
Last Posted Date
2024-06-27
Lead Sponsor
Peking Union Medical College Hospital
Target Recruit Count
56
Registration Number
NCT06478537
Locations
🇨🇳

Peking Union Medical College Hospital, Beijing, Beijing, China

IndObufen Versus asPirin After Coronary Drug-eluting Stent implantaTION in Elderly Patients With Acute Coronary Syndrome

Phase 4
Not yet recruiting
Conditions
Interventions
First Posted Date
2024-06-11
Last Posted Date
2024-06-18
Lead Sponsor
Shanghai Zhongshan Hospital
Target Recruit Count
2846
Registration Number
NCT06451198

The Nordic Aortic Valve Intervention Trial 4 (NOTION-4)

First Posted Date
2024-06-10
Last Posted Date
2024-06-10
Lead Sponsor
Rigshospitalet, Denmark
Target Recruit Count
324
Registration Number
NCT06449469
Locations
🇩🇰

Aarhus University Hospital, Skejby, Aarhus, Denmark

🇩🇰

Rigshospitalet, Copenhagen, Denmark

Assessment of Gastrointestinal Blood Loss After Receiving Aspirin or Aspirin Plus Rivaroxaban, or Aspirin Plus REGN9933, or Aspirin Plus REGN7508 in Healthy Adult Participants

First Posted Date
2024-06-05
Last Posted Date
2024-10-09
Lead Sponsor
Regeneron Pharmaceuticals
Target Recruit Count
224
Registration Number
NCT06444178
Locations
🇬🇧

Fortrea Clinical Development, Leeds, United Kingdom

© Copyright 2024. All Rights Reserved by MedPath